CIRM and Medical University of Warsaw Collaborate
News Nov 21, 2014
California’s state stem cell agency, the California Institute for Regenerative Medicine (CIRM), and the Medical University of Warsaw (MUW), a Polish state institution, announced today an international collaboration on stem cell research.
The agreement was signed today at an event attended by Katarzyna Kacperczyk, Deputy Minister of Foreign Affairs of the Republic of Poland and Prof. Krzysztof Kurzydlowski, Director of the National Center for Research and Development along with other dignitaries from Poland and the leadership of CIRM at the agency’s headquarters.
CIRM and MUW are laying the foundation for potential joint Polish-Californian research initiatives to advance stem cell therapies through collaborations among innovators in the field. The agreement will make it easier for researchers in California and Poland to obtain joint funding and to exchange know-how in the area of regenerative medicine.
“Poland has a robust stem cell research community, which should create synergies with researchers in California and help us further leverage California’s investment in the field for the good of patients everywhere,” said Jonathan Thomas, chair of CIRM’s governing Board.
“We are committed to supporting Polish researchers to work with California scientists and businesses to further boost Poland’s profile as an innovative and accelerating center for scientific research,” said Piotr Moncarz, consulting professor at Stanford University, co-founder and chairman of US-Polish Trade Council, the organization which presented the idea of this Agreement to the Leadership of CIRM and to the Rector of WMU, Prof. Marek Krawczyk, M.D.
Cell Technology Used to Treat Osteochondral Knee DefectNews
Autologous cells of stromal vascular fraction were transplanted to a 36-year-old man with the use of fibrin matrix.READ MORE
Gene Editing Technology May Improve Accuracy of Predicting Heart Disease RiskNews
Scientists may now be able to predict whether carrying a specific genetic variant increases a person’s risk for disease using gene editing and stem cell technologies.READ MORE